Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

180.87 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9
...
78 79 Next >
Why Moderna Stock Is Surging After Hours
Moderna Inc (NASDAQ: MRNA) shares are trading higher in Tuesday's after-hours session after the company announced topline data from a Phase 3 trial of the company's 
Via Benzinga
Pfizer (PFE) Stock Falls on Analyst Downgrade
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock. 
Via InvestorPlace
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
The U.S. 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
3 Biopharma Stocks That Could Help Make You a Fortune
All three are protected by sales of in-demand products, with more on the way. 
Via The Motley Fool
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. 
Via Benzinga
$100 Invested In Moderna 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
2 Top Growth Stocks to Buy Right Now and Hold for the Long Term
Medicine and computer chips have a lot of growth runway ahead. 
Via The Motley Fool
5 Potentially Explosive Stocks to Buy in 2023
These stocks all dropped in the double digits last year. But their future prospects are brilliant. 
Via The Motley Fool
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
Small-cap speculative biotech stocks regain interest with volatility. 
Via Talk Markets
Looking At Moderna's Recent Unusual Options Activity
A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 20 strange trades. 
Via Benzinga
How Is The Market Feeling About Moderna?
Moderna's (NASDAQ:MRNA) short percent of float has fallen 15.79% since its last report. The company recently reported that it has 14.04 million shares sold short, which is 4.96% of all regular shares... 
Via Benzinga
Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish
2023 can be the year of biotechs after two consecutive years of negative or barely positive returns. 
Via Talk Markets
7 Hot Healthcare Stocks to Watch in 2023
Strong earnings and robust dividend payments make healthcare stocks attractive during times of uncertainty and volatility. 
Via InvestorPlace
If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two and a half years. But there was no question some big-name stocks performed... 
Via Benzinga
Is Alexandria Real Estate Equity a Buy?
It's a great stock, but investors dislike the sector. 
Via The Motley Fool
Exclusive: Top 10 Most Searched Tickers On Benzinga Pro In 2022 — Where Do SPY, Tesla, Apple And AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a leading source for traders to see the latest news on the overall market and individual tickers all in one... 
Via Benzinga
Moderna's Interim Earnings Beat Modestly, Uncertainty Looms Over 2023
 
Via Benzinga
Why Is Ocugen (OCGN) Stock Up Today?
Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines. 
Via InvestorPlace
Tesla, Moderna And These 2 Stocks Insiders Are Selling
The US economy added 223,000 jobs in December, the least since December 2020, following a revised 256,000 increase in November, and above market estimates of 200,000. Investors, meanwhile, focused on... 
Via Benzinga
China In Talks To Secure License For Generic Version Of Pfizer's COVID-19 Oral Drug
China is reportedly in talks with Pfizer Inc (NYSE: PFE) to secure a license allowing domestic drugmakers to manufacture and distribute a generic version of its COVID-19 antiviral Paxlovid. 
Via Benzinga
Top Nasdaq 100 Stocks: Trading Opportunities For Next Week - Sunday, Jan. 8
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some Nasdaq 100 stock opportunities... 
Via Talk Markets
Looking for Growth in 2023? Where to Invest $5,000
Over time, some of last year's losers could win big. 
Via The Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
Via InvestorPlace
CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal
CytomX Therapeutics announced a licensing deal with Moderna, which may supercharge the underlying ambitions of CTMX stock. 
Via InvestorPlace
CytomX Shares Move Higher On Collaborating Pact With This Famed COVID-19 Vaccine Maker
 
Via Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
Via Investor's Business Daily
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday! 
Via InvestorPlace
Many Investors Wouldn't Touch This Stock With a 10-Foot Pole Last Year. Here's Why It's a Buy in 2023.
Moderna's vaccine earnings are helping it prepare for the future. 
Via The Motley Fool
Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?
Merck has a number of efforts in the works to help avoid a Keytruda generics pitfall. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
78 79 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.